Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-15

Clinical Trial Update: Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (HEATWAVE) is evaluating apalutamide in combination with image-guided stereotactic body radiation therapy for prostate cancer. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERLEADA (apalutamide)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8 | Phase 2 | Status: RECRUITING